Biomedical Entrepreneurship: From Research Laboratories to Global Markets

Abstract

Biomedical entrepreneurship represents a crucial intersection between scientific innovation, health technology, and global economic growth. Over the last two decades, the transformation of biomedical discoveries into viable commercial ventures has reshaped healthcare delivery and generated new drivers of international competitiveness. This paper explores the mechanisms through which research-based biomedical innovations evolve into globally scalable enterprises. The study employs a qualitative synthesis of peer-reviewed literature, global case studies, and innovation ecosystem data to identify the critical factors influencing this transition. Results reveal that successful biomedical entrepreneurship depends on three interlinked pillars: translational research capability, ecosystem support structures (including funding, incubators, and regulation), and integration into international markets. The paper contributes to the field of study by developing a conceptual framework - the Biomedical Entrepreneurship Globalization (BEG) Model - linking local research ecosystems with global commercialization outcomes. This framework underscores the way biomedical entrepreneurship not only accelerates technological progress but also strengthens public health resilience and global economic stability.